In non-small cell lung cancer, the expression of the β-TrCP2 is inhibited by miR-106b-25 (83), while FBXW7 agonist (Oridonin) contributes to the degradation of Snail1 (89). This evidence concerns the gene SNAI1 and non-small cell lung carcinoma.